EV/EBITDA
-6.75
-0.16-2.43%
6 min ago
Summary
- As of February 24, 2025, YMAB EV/EBITDA is -6.75, with a fall of -0.16 (-2.43%) during the most recent trading day.
- Over the past year, YMAB EV/EBITDA has increased by +19.12 (+73.91%).
- YMAB EV/EBITDA is now -4721.43% below its all-time high of -0.14.
Performance
YMAB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
YMAB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.4% | +2.4% | +1.8% |
| 1 m1 month | +11.7% | -11.6% | -8.8% |
| 3 m3 months | +52.9% | -52.8% | -45.2% |
| 6 m6 months | +67.4% | -66.3% | -60.1% |
| ytdytd | +35.4% | -35.4% | -28.8% |
| 1 y1 year | +73.9% | -70.8% | -65.5% |
| 5 y5 years | +45.9% | -81.8% | -81.7% |
YMAB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.4% | -8.01 | +15.7% | |
| 3 m | 3-month | -6.59 | -2.4% | -16.91 | +60.1% |
| 6 m | 6-month | -6.59 | -2.4% | -22.81 | +70.4% |
| 1 y | 1-year | -6.59 | -2.4% | -33.59 | +79.9% |
| 3 y | 3-year | -0.14 | -4721.4% | -33.59 | +79.9% |
| 5 y | 5-year | -0.14 | -4721.4% | -33.92 | +80.1% |
| alltime | all time | -0.14 | -4721.4% | -33.92 | +80.1% |
Y-mAbs Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.75(-35.4%) |
| 2024 | -10.45(+18.3%) |
| 2023 | -8.83(+661.2%) |
| 2022 | -1.16(-88.5%) |
| Date | Value |
|---|---|
| 2021 | -10.08(-36.7%) |
| 2020 | -15.93(+27.3%) |
| 2019 | -12.51(-1.3%) |
| 2018 | -12.68 |
FAQ
- What is Y-mAbs Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Y-mAbs Therapeutics?
- What is YMAB EV/EBITDA year-to-date change?
- What is Y-mAbs Therapeutics EV/EBITDA year-on-year change?
What is Y-mAbs Therapeutics EV/EBITDA?
The current EV/EBITDA of YMAB is -6.75
What is the all time high EV/EBITDA for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high EV/EBITDA is -0.14
What is YMAB EV/EBITDA year-to-date change?
Y-mAbs Therapeutics EV/EBITDA has changed by +3.70 (+35.41%) since the beginning of the year
What is Y-mAbs Therapeutics EV/EBITDA year-on-year change?
Over the past year, YMAB EV/EBITDA has changed by +19.12 (+73.91%)